12:33 PM EST - Nirvana Life Sciences Inc : Announced that its supply agreement with Symeres B.V. has produced its first 20 grams of Psilocybin and 20 grams of Psilocin. These materials will support the Company's ongoing research and development projects. Nirvana Life Sciences Inc
shares C.NIRV are trading down $0.03 at $0.58.
